Pharmaceutical - Denmark

Filter

Current filters:

Denmark

Popular Filters

ALK Abello reports strong improvement in 2nd-qtr financials

ALK Abello reports strong improvement in 2nd-qtr financials

13-08-2014

Denmark-based allergy specialist ALK Abello has reported significant progress in its sales for the second…

ALK AbelloDenmarkFinanceFinancialNorwegian kronePharmaceuticalRespiratory and Pulmonary

GSK and Genmab announce positive interim results for ofatumumab Phase III

GSK and Genmab announce positive interim results for ofatumumab Phase III

01-08-2014

UK Pharma major GlaxoSmithKline and Danish biotechnology company Genmab have said that an interim analysis…

Chronic lymphocytic leukemiaDenmarkGenmabGSKOfatumumabOfatumumab InjectionOncologyPharmaceuticalRafael AmadoResearchUK

Zealand and Boehringer link up to advance novel peptide medicines

Zealand and Boehringer link up to advance novel peptide medicines

28-07-2014

Denmark’s Zealand Pharma has entered into a new global exclusive licence and R&D collaboration with…

Boehringer IngelheimCardio-vascularDenmarkFinancialGermanyLicensingMetabolicsPharmaceuticalResearchZealand Pharma

ALK appoints new Executive Vice President for Product Supply

ALK appoints new Executive Vice President for Product Supply

01-07-2014

Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product…

ALK AbelloAlk-AbelloBoardroomDenmarkPharmaceutical

Brintellix meets primary efficacy end-point in depression study

Brintellix meets primary efficacy end-point in depression study

26-06-2014

Danish CNS drug specialist Lundbeck has announced results of the SOLUTION trial conducted in Asian patients…

BrintellixDenmarkLundbeckNeurologicalPharmaceuticalResearch

Lundbeck’s Brintellix shows efficacy in cognitive function study

Lundbeck’s Brintellix shows efficacy in cognitive function study

16-06-2014

Danish CNS drug specialist Lundbeck has announced results from the CONNECT study showing that Brintellix…

BrintellixDenmarkDepressionLundbeckNeurologicalPharmaceuticalResearch

6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark

6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark

11-06-2014

Up to 2022, Danish diabetes care giant Novo Nordisk expects to hire 6,000 new employees in Denmark, half…

BoardroomDenmarkDiabetesManagementNovo NordiskPharmaceutical

Lundbeck releases positive results from six-year Onfi study

Lundbeck releases positive results from six-year Onfi study

12-03-2014

Danish CNS drug specialist Lundbeck has published results from a long-term, open-label extension study…

DenmarkLundbeckNeurologicalOnfiPharmaceuticalResearch

ALK’s partner for Japan reports positive trial results for house dust mite SLIT-tablet

10-03-2014

Denmark-based allergy specialist ALK Abello said that its Japanese partner Torii Pharmaceutical has reported…

ALK AbelloDenmarkImmunologicalsJapanPharmaceuticalResearchTorii Pharma

Novo Nordisk’s novel therapy could offer better outcomes for type 2 diabetes patients

Novo Nordisk’s novel therapy could offer better outcomes for type 2 diabetes patients

05-03-2014

Danish insulin giant Novo Nordisk has presented positive data at the Diabetes UK conference from its…

DenmarkDiabetesIDegLiraNovo NordiskPharmaceuticalResearchUK

Lundbeck raises $1.2 million by increasing share capital

Lundbeck raises $1.2 million by increasing share capital

19-02-2014

Danish CNS drug specialist Lundbeck will raise 6,753,283 Danish kroner ($1,242,714) by increasing its…

DenmarkFinancialLundbeckPharmaceutical

Topotargetin receives $17.8 million in milestone payments and could receive another $25 million

10-02-2014

Danish oncology drug development company Topotargetin (OMX: TOPO) has been the subject of an increased…

belinostatDenmarkFinancialOncologyPharmaceuticalTopotarget

ALK’s 2013 annual report shows profit down but sales steady

ALK’s 2013 annual report shows profit down but sales steady

05-02-2014

Denmark-based allergy specialist ALK Abello (ALKB: DC) has released its annual report for 2013 recording…

ALK AbelloDenmarkFinancialImmunologicalsPharmaceutical

Novo Nordisk’s profits rise 15% with further growth expected

Novo Nordisk’s profits rise 15% with further growth expected

30-01-2014

Danish insulin giant Novo Nordisk has announced a 15% growth in profit in the firm’s 2013 financial…

DenmarkDiabetesFinancialNovo NordiskPharmaceuticalTresibaVictoza

Lundbeck and Otsuka’s brexpiprazole shows efficacy in Phase III trial

Lundbeck and Otsuka’s brexpiprazole shows efficacy in Phase III trial

24-01-2014

Danish CNS drug specialist Lundbeck (LUND: CO) and Japanese drug maker Otsuka (TYO: 4768) have revealed…

brexpiprazoleDenmarkLundbeckNeurologicalOtsukaPharmaceuticalResearch

“Differing views” see Zealand and Boehringer change collaboration compound

“Differing views” see Zealand and Boehringer change collaboration compound

20-01-2014

Zealand Pharma and Boehringer Ingelheim will change the development program involving novel glucagon/GLP-1…

Boehringer IngelheimDenmarkDiabetesGermanyPharmaceuticalResearchZealand Pharma

Danish pharma bemoans lack of PM comment on unitary European patent system

Danish pharma bemoans lack of PM comment on unitary European patent system

18-01-2014

It could be crucially important for growth, exports and employment in Denmark. But not a word was said…

DenmarkNorthern EuropePatentsPharmaceuticalPolitics

Sandoz receives Danish approval for AirFluSal Forspiro inhaler

Sandoz receives Danish approval for AirFluSal Forspiro inhaler

19-12-2013

Swiss drug major Novartis' (NOVN: VX) generics unit Sandoz has received Danish marketing authorization…

DenmarkPharmaceuticalRegulationRespiratory and PulmonarySandozVectura

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

16-12-2013

Danish pharmaceutical company H. Lundbeck A/S has appointed Jacob Tolstrup as head of the HR department…

BoardroomDenmarkEuropeH. LundbeckLundbeckNeurologicalPharmaceutical

Novo Nordisk accused of delaying information release under Danish STC rules

Novo Nordisk accused of delaying information release under Danish STC rules

10-12-2013

Danish insulin giant Novo Nordisk revealed this morning that the Danish Financial Supervisory Authority…

DenmarkDiabetesEuropeFinancialLegalNovo NordiskPharmaceuticalRyzodegTresiba

Nuevolution appoints Ton Berkien as chief business officer

Nuevolution appoints Ton Berkien as chief business officer

09-12-2013

Denmark-based small molecule lead discovery company Nuevolution A/S has appointed Ton Berkien as Chief…

BoardroomDenmarkEuropeNuevolutionPharmaceutical

Back to top